Luis Brieva Ruiz
Grau: Doctor/a
973 705 367
lbrieva.lleida.ics(ELIMINAR)@gencat.cat
ResearcherID: https://www.researcherid.com/rid/E-8505-2019
Grups
Publicacions
-
Oreja-Guevara, C; Ayuso Blanco T; Brieva Ruiz L; Hernández Pérez MÁ; Meca-Lallana, V; Ramió-Torrentà L
Cognitive Dysfunctions and Assessments in Multiple Sclerosis
Frontiers in Neurology 10 581-581. .
-
Fernandez, O; Tintore, M; Saiz, A; Calles-Hernandez, MC; Comabella, M; Ramio-Torrenta, L; Oterino, A; Izquierdo, G; Tellez, N; Garcia-Merino JA; Brieva, L; Arnal-Garcia, C; Aladro, Y; Mendibe-Bilbao, MD; Meca-Lallana, JE; Romero-Pinel, L; Martinez-Gines, ML; Arroyo, R; Oreja-Guevara, C; Costa-Frossard, L; Carrascal, P; Rodriguez-Antiguedad, A
Review of the novelties presented at the 2018 ECTRIMS Congress: 11th Post-ECTRIMS Meeting (II)
REVISTA DE NEUROLOGIA 68 468-479. .
-
Fernandez, O; Tintore, M; Saiz, A; Calles-Hernandez, MC; Comabella, M; Ramio-Torrenta, L; Oterino, A; Izquierdo G; Tellez, N; Garcia-Merino JA; Brieva, L; Arnal-Garcia, C; Aladro, Y; Mendibe-Bilbao, MD; Meca-Lallana, JE; Romero-Pinel, L; Martinez-Gines, ML; Arroyo, R; Oreja-Guevara, C; Costa-Frossard, L; Carrascal, P; Rodriguez-Antiguedad, A
Review of the novelties presented at the 2018 ECTRIMS Congress: 11th Post-ECTRIMS Meeting (I)
REVISTA DE NEUROLOGIA 68 431-441. .
-
Hervas-Garcia, JV; Ramio-Torrenta, L; Brieva-Ruiz, L; Batlle-Nadal, J; Moral, E; Blanco, Y; Cano-Orgaz, A; Presas-Rodriguez, S; Torres, F; Capellades, J; Ramo-Tello, C
Comparison of two high doses of oral methylprednisolone for multiple sclerosis relapses: a pilot, multicentre, randomized, double-blind, non-inferiority trial
EUROPEAN JOURNAL OF NEUROLOGY 26 525-532. .
-
Quirant-Sanchez, B; Presas-Rodriguez, S; Mansilla, MJ; Teniente-Serra, A; Hervas-Garcia, JV; Brieva, L; Moral-Torres, E; Cano, A; Munteis, E; Navarro-Barriuso, J; Martinez-Caceres, EM; Ramo-Tello, C
Th1Th17(CM) Lymphocyte Subpopulation as a Predictive Biomarker of Disease Activity in Multiple Sclerosis Patients under Dimethyl Fumarate or Fingolimod Treatment
MEDIATORS OF INFLAMMATION 2019 8147803-8147803. .
-
González Mingot C; Juárez Turégano A; Bosch Gaya A; Brieva Ruiz L
Cardiogenic shock in clinically isolated syndrome
NEUROLOGIA 34 69-72. .
-
Sepulveda, M; Aldea, M; Escudero, D; Llufriu, S; Arrambide, G; Otero-Romero, S; Sastre-Garriga, J; Romero-Pinel, L; Martinez-Yelamos, S; Sola-Valls, N; Armangue, T; Sotoca, J; Escartin, A; Robles-Cedeno, R; Ramio-Torrent, L; Presas-Rodriguez, S; Ramo-Tello, C; Munteis, E; Pelayo, R; Gubieras, L; Brieva, L; Ortiz, N; Hervas, M; Mañé-Martínez MA; Cano, A; Vela, E; Tintore, M; Blanco, Y; Montalban, X; Graus, F; Saiz, A
Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates
Multiple Sclerosis Journal 24 1843-1851. .
-
Quirant-Sanchez, B; Hervas-Garcia, JV; Teniente-Serra, A; Brieva, L; Moral-Torres, E; Cano, A; Munteis, E; Mansilla, MJ; Presas-Rodriguez, S; Navarro-Barriuso, J; Ramo-Tello, C; Martinez-Caceres, EM
Predicting therapeutic response to fingolimod treatment in multiple sclerosis patients
CNS Neuroscience & Therapeutics 24 1175-1184. .
-
Gil, A; Pardinas, B; Hervas, V; Lecina, J; Solana, MJ; Peralta, S; Forne, C; Gonzalez, C; Gonzalo, H; Nogueras, L; Brieva, L
Pilot Study of Telemedicine in multiple sclerosis to evaluate the effectiveness of a telecommunication system for the detection of the clinical activity of the disease in the number of relapses with respect to the standard clinical practice. TELEM
Multiple Sclerosis Journal 24 795-796. .
-
Fernandez, O; Tintore, M; Saiz, A; Calles-Hernandez, MC; Comabella, M; Ramio-Torrenta, L; Oterino, A; Izquierdo, G; Tellez, N; Garcia-Merino, JA; Brieva, L; Arnal-Garcia, C; Aladro, Y; Mendibe-Bilbao, MD; Meca-Lallana, JE; Romero-Pinel, L; Ginestal, R; Martinez-Gines, ML; Arroyo, R; Rodriguez-Antiguedad, A
Review of the novelties from the 2017 ECTRIMS Congress, presented at the 10th Post- ECTRIMS Meeting ( II)
REVISTA DE NEUROLOGIA 67 50-62. .
-
Fernandez, O; Tintore, M; Saiz, A; Calles-Hernandez, MC; Comabella, M; Ramio-Torrenta, L; Oterino, A; Izquierdo, G; Tellez, N; Garcia-Merino, JA; Brieva, L; Arnal-Garcia, C; Aladro, Y; Mendibe-Bilbao, MD; Meca-Lallana, JE; Romero-Pinel, L; Ginestal, R; Martinez-Gines, ML; Arroyo, R; Rodriguez-Antiguedad, A
Review of the novelties from the 2017 ECTRIMS Congress, presented at the 10th Post-ECTRIMS Meeting (I)
REVISTA DE NEUROLOGIA 67 15-27. .
-
Nogueras Penabad, L.; Gil Sanchez, A.; Hervas, J. V.; Gonzalez, C.; Marti, M.; Canudes, M.; Peralta, S.; Moga, M. J.; Boada, J.; Pamplona, R.; Portero, M.; Brieva, L.; Gonzalo, H.
Mitochondrial dysfunction in peripheral blood mononuclear cells from multiple sclerosis patients
Multiple Sclerosis Journal 23 509-509. .
Projectes
- Contribución de los productos finales de la glicación avanzada (AGEs) a la fisiopatología neurocognitiva de la esclerosis múltiple: Desvelando el daño silencioso. CAGEP-EM
- PROLILEM: DesEMmascarando la Esclerosis Múltiple con biomarcadores pronósticos liídicos
- EMCOVID-19: Esclerosis Múltiple y COVID-19
- "Registro de pacientes con esclerosis múltiple (EM) tratados con Natalizumab en España"
- UTILIDAD DE LA REALIZACION DE SECUENCIAS DE DIFUSION Y LA DETERMINACION DE BIOMARCADORES EN EL PRONOSTICO DE LOS PACIENTES CON UN ATAQUE ISQUEMICO TRANSITORIO